A detailed history of Cetera Investment Advisers transactions in Johnson & Johnson stock. As of the latest transaction made, Cetera Investment Advisers holds 644,526 shares of JNJ stock, worth $94.4 Million. This represents 0.24% of its overall portfolio holdings.

Number of Shares
644,526
Previous 652,030 1.15%
Holding current value
$94.4 Million
Previous $95.3 Million 9.6%
% of portfolio
0.24%
Previous 0.23%

Shares

32 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024

SELL
$145.48 - $167.38 $1.09 Million - $1.26 Million
-7,504 Reduced 1.15%
644,526 $104 Million
Q2 2024

Aug 22, 2024

SELL
$144.38 - $157.78 $7.98 Million - $8.72 Million
-55,243 Reduced 7.81%
652,030 $95.3 Million
Q1 2024

May 24, 2024

BUY
$155.22 - $162.74 $93.5 Million - $98.1 Million
602,532 Added 575.26%
707,273 $112 Million
Q1 2024

May 14, 2024

SELL
$155.22 - $162.74 $17.6 Million - $18.5 Million
-113,577 Reduced 52.02%
104,741 $16.6 Million
Q4 2023

Feb 13, 2024

SELL
$145.6 - $158.88 $495,768 - $540,986
-3,405 Reduced 1.54%
218,318 $34.2 Million
Q3 2023

Nov 14, 2023

SELL
$155.75 - $174.48 $377,226 - $422,590
-2,422 Reduced 1.08%
221,723 $34.5 Million
Q2 2023

Aug 09, 2023

SELL
$154.35 - $166.11 $136,136 - $146,509
-882 Reduced 0.39%
224,145 $37.1 Million
Q1 2023

May 15, 2023

BUY
$151.05 - $180.26 $843,916 - $1.01 Million
5,587 Added 2.55%
225,027 $34.9 Million
Q4 2022

Feb 14, 2023

BUY
$160.2 - $179.79 $11.5 Million - $12.9 Million
71,737 Added 48.57%
219,440 $38.8 Million
Q3 2022

Nov 10, 2022

SELL
$161.33 - $179.52 $6.16 Million - $6.85 Million
-38,163 Reduced 20.53%
147,703 $24.1 Million
Q2 2022

Aug 11, 2022

BUY
$168.19 - $186.01 $3.4 Million - $3.76 Million
20,224 Added 12.21%
185,866 $33 Million
Q1 2022

May 13, 2022

BUY
$158.14 - $179.59 $635,722 - $721,951
4,020 Added 2.49%
165,642 $29.4 Million
Q4 2021

Feb 14, 2022

BUY
$155.93 - $173.01 $512,541 - $568,683
3,287 Added 2.08%
161,622 $27.6 Million
Q3 2021

Nov 16, 2021

BUY
$161.5 - $179.47 $146,803 - $163,138
909 Added 0.58%
158,335 $25.6 Million
Q2 2021

Aug 13, 2021

BUY
$159.48 - $171.07 $2.13 Million - $2.29 Million
13,366 Added 9.28%
157,426 $25.9 Million
Q1 2021

May 17, 2021

SELL
$153.07 - $170.48 $686,825 - $764,943
-4,487 Reduced 3.02%
144,060 $23.7 Million
Q4 2020

Feb 17, 2021

BUY
$137.11 - $157.38 $14.6 Million - $16.7 Million
106,404 Added 252.48%
148,547 $23.4 Million
Q3 2020

Nov 13, 2020

BUY
$140.38 - $153.83 $407,242 - $446,260
2,901 Added 7.39%
42,143 $6.27 Million
Q2 2020

Aug 13, 2020

BUY
$128.81 - $155.51 $453,668 - $547,706
3,522 Added 9.86%
39,242 $5.52 Million
Q1 2020

May 08, 2020

BUY
$111.14 - $153.99 $230,170 - $318,913
2,071 Added 6.15%
35,720 $4.68 Million
Q4 2019

Feb 10, 2020

BUY
$127.5 - $146.44 $130,687 - $150,101
1,025 Added 3.14%
33,649 $4.91 Million
Q3 2019

Nov 06, 2019

SELL
$126.95 - $142.14 $148,023 - $165,735
-1,166 Reduced 3.45%
32,624 $4.22 Million
Q2 2019

Aug 12, 2019

BUY
$131.15 - $144.24 $207,217 - $227,899
1,580 Added 4.91%
33,790 $4.71 Million
Q1 2019

May 06, 2019

BUY
$125.72 - $139.79 $19,109 - $21,248
152 Added 0.47%
32,210 $4.51 Million
Q4 2018

Feb 15, 2019

SELL
$122.84 - $147.84 $364,711 - $438,936
-2,969 Reduced 8.48%
32,058 $4.14 Million
Q3 2018

Nov 14, 2018

BUY
$121.58 - $142.88 $236,959 - $278,473
1,949 Added 5.89%
35,027 $4.84 Million
Q2 2018

Aug 14, 2018

SELL
$119.4 - $131.76 $406,915 - $449,038
-3,408 Reduced 9.34%
33,078 $4.01 Million
Q1 2018

May 09, 2018

SELL
$125.1 - $148.14 $240,567 - $284,873
-1,923 Reduced 5.01%
36,486 $4.68 Million
Q4 2017

Feb 08, 2018

BUY
$131.22 - $143.62 $178,327 - $195,179
1,359 Added 3.67%
38,409 $5.36 Million
Q3 2017

Nov 16, 2017

BUY
$129.47 - $135.38 $549,341 - $574,417
4,243 Added 12.93%
37,050 $4.83 Million
Q2 2017

Aug 17, 2017

SELL
N/A
-32,074 Reduced 49.44%
32,807 $4.33 Million
Q2 2017

Aug 14, 2017

BUY
N/A
64,881
64,881 $8.58 Million

Others Institutions Holding JNJ

About JOHNSON & JOHNSON


  • Ticker JNJ
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,614,479,872
  • Market Cap $383B
  • Description
  • Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide. The company's Consumer Health segment offers baby care products under the JOHNSON'S and AVEENO Baby brands; oral care products under the LISTERINE brand; skin health/beauty products under the...
More about JNJ
Track This Portfolio

Track Cetera Investment Advisers Portfolio

Follow Cetera Investment Advisers and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Cetera Investment Advisers, based on Form 13F filings with the SEC.

News

Stay updated on Cetera Investment Advisers with notifications on news.